Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516, USA.
Pharmacogenet Genomics. 2013 Aug;23(8):395-402. doi: 10.1097/FPC.0b013e328362f9f2.
We have previously reported a top-ranked risk gene [i.e., serine incorporator 2 gene (SERINC2)] for alcohol dependence in individuals of European descent by analyzing the common variants in a genome-wide association study. In the present study, we comprehensively examined the rare variants [minor allele frequency (MAF)<0.05] in the NKAIN1-SERINC2 region to confirm our previous finding.
A discovery sample (1409 European-American patients with alcohol dependence and 1518 European-American controls) and a replication sample (6438 European-Australian family participants with 1645 alcohol-dependent probands) were subjected to an association analysis. A total of 39,903 individuals from 19 other cohorts with 11 different neuropsychiatric and neurological disorders served as contrast groups. The entire NKAIN1-SERINC2 region was imputed in all cohorts using the same reference panels of genotypes that included rare variants from the whole-genome sequencing data. We stringently cleaned the phenotype and genotype data, and obtained a total of about 220 single-nucleotide polymorphisms in individuals of European descent and about 450 single-nucleotide polymorphisms in the individuals of African descent with 0<MAF<0.05 for an association analysis.
Using a weighted regression analysis implemented in the program SCORE-Seq, we found a rare variant constellation across the entire NKAIN1-SERINC2 region that was associated with alcohol dependence in European-Americans (Fp: overall, P=1.8×10(-4); VT: overall, P=1.4×10(-4); Collapsing, P=6.5×10(-5)) and European-Australians (Fp: overall, P=0.028; Collapsing, P=0.025), but not in African-Americans, and not associated with any other disorder examined. Association signals in this region came mainly from SERINC2, a gene that codes for an activity-regulated protein expressed in the brain that incorporates serine into lipids. In addition, 26 individual rare variants were nominally associated with alcohol dependence in European-Americans (P<0.05). The associations of five of these rare variants that lay within SERINC2 showed region-wide significance (P<α=0.0006) and 25 associations survived correction for a false discovery rate (q<0.05). The associations of two rare variants at SERINC2 were replicated in European-Australians (P<0.05).
We concluded that SERINC2 was a replicable and significant risk gene specific for alcohol dependence in individuals of European descent.
我们之前通过全基因组关联研究分析了欧洲血统个体中常见的变体,发现了一个排名靠前的酒精依赖风险基因[即丝氨酸掺入因子 2 基因 (SERINC2)]。在本研究中,我们全面研究了 NKAIN1-SERINC2 区域的罕见变异(次要等位基因频率 (MAF)<0.05),以确认我们之前的发现。
一个发现样本(1409 名患有酒精依赖的欧洲裔美国人患者和 1518 名欧洲裔美国人对照)和一个复制样本(6438 名患有酒精依赖的欧洲裔澳大利亚家族参与者和 1645 名酒精依赖的先证者)进行了关联分析。来自 19 个不同的神经精神和神经科队列的 39903 名个体作为对照群体,这些队列具有 11 种不同的神经精神和神经科疾病。使用包含全基因组测序数据中罕见变体的相同参考面板,对所有队列中的整个 NKAIN1-SERINC2 区域进行了推断。我们严格清理了表型和基因型数据,在欧洲血统个体中获得了大约 220 个单核苷酸多态性,在非洲血统个体中获得了大约 450 个单核苷酸多态性,这些个体的 0<MAF<0.05 可用于关联分析。
使用程序 SCORE-Seq 中实现的加权回归分析,我们发现整个 NKAIN1-SERINC2 区域存在一个与欧洲裔美国人的酒精依赖相关的罕见变异组合(Fp:总体,P=1.8×10(-4);VT:总体,P=1.4×10(-4);Collapsing,P=6.5×10(-5))和欧洲裔澳大利亚人(Fp:总体,P=0.028;Collapsing,P=0.025),但在非洲裔美国人中不存在,也与我们检查的任何其他疾病无关。该区域的关联信号主要来自 SERINC2,这是一种在大脑中表达的活性调节蛋白,可将丝氨酸掺入脂质中。此外,26 个个体罕见变体在欧洲裔美国人中与酒精依赖呈显著相关(P<0.05)。其中五个位于 SERINC2 内的罕见变体的关联具有全区域显著性(P<α=0.0006),25 个关联在经过错误发现率校正后仍具有统计学意义(q<0.05)。SERINC2 中的两个罕见变体的关联在欧洲裔澳大利亚人中得到了复制(P<0.05)。
我们得出结论,SERINC2 是欧洲血统个体中酒精依赖的可重复和重要的风险基因。